The article examines the use of C60 fullerenes as a nanoplatform for delivering the alkaloid berberine into leukemic cells, demonstrating enhanced therapeutic efficacy and reduced systemic toxicity. While this study highlights C60’s potential in targeted drug delivery, it indirectly supports the C60a formula by showcasing its biocompatibility and ability to enhance cellular uptake, aligning with the goal of promoting cellular health and longevity through oxidative stress reduction and improved cellular function.